{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:00:00Z","timestamp":1790794800291,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03561-w","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:37:20Z","timestamp":1790793440000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Folic Acid-Conjugated Solid Lipid Nanoparticles for Ratiometric Combination Delivery of Docetaxel and Erlotinib in Triple-Negative Breast Cancer Therapy"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6045-6590","authenticated-orcid":false,"given":"Aiswarya","family":"Chaudhuri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2415-7806","authenticated-orcid":false,"given":"Dulla Naveen","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7756-191X","authenticated-orcid":false,"given":"Rohan Chand","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9785-0500","authenticated-orcid":false,"given":"Dinesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7302-3647","authenticated-orcid":false,"given":"Ashish Kumar","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"3561_CR1","doi-asserted-by":"publisher","unstructured":"Fasinu P, Pillay V, Ndesendo VM, du Toit LC, YE. C. Diverse approaches for the enhancement of oral drug bioavailability. Biopharm Drug Dispos. 2011;32(4):185\u2013209. https:\/\/doi.org\/10.1002\/bdd.750.","DOI":"10.1002\/bdd.750"},{"issue":"8","key":"3561_CR2","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3109\/03639040903585143","volume":"36","author":"SK Singh","year":"2010","unstructured":"Singh SK, Verma PR, Razdan B. Glibenclamide-loaded self-nanoemulsifying drug delivery system: development and characterization. Drug Dev Ind Pharm. 2010;36(8):933\u201345. https:\/\/doi.org\/10.3109\/03639040903585143.","journal-title":"Drug Dev Ind Pharm"},{"key":"3561_CR3","doi-asserted-by":"publisher","unstructured":"Emerich DF, CG. T. Targeted nanoparticle-based drug delivery and diagnosis. J Drug Target. 2007;15(3):163\u201383. https:\/\/doi.org\/10.1080\/10611860701231810.","DOI":"10.1080\/10611860701231810"},{"key":"3561_CR4","doi-asserted-by":"publisher","unstructured":"Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, OC F. Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther. 2008;83(5):761\u20139. https:\/\/doi.org\/10.1038\/sj.clpt.6100400.","DOI":"10.1038\/sj.clpt.6100400"},{"key":"3561_CR5","doi-asserted-by":"publisher","unstructured":"Ghasemiyeh P, S M-S. Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages. Res Pharm Sci. 2018;13(4):288\u2013303. https:\/\/doi.org\/10.4103\/1735-5362.235156.","DOI":"10.4103\/1735-5362.235156"},{"issue":"2","key":"3561_CR6","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ijpharm.2011.12.037","volume":"424","author":"M Ghadiri","year":"2012","unstructured":"Ghadiri M, Fatemi S, Vatanara A, Doroud D, Najafabadi AR, Darabi M, et al. Loading hydrophilic drug in solid lipid media as nanoparticles: statistical modeling of entrapment efficiency and particle size. Int J Pharm. 2012;424(2):128\u201337. https:\/\/doi.org\/10.1016\/j.ijpharm.2011.12.037.","journal-title":"Int J Pharm"},{"issue":"2","key":"3561_CR7","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ejps.2013.03.013","volume":"49","author":"H Vaghasiya","year":"2013","unstructured":"Vaghasiya H, Kumar A, Sawant K. Development of solid lipid nanoparticles based controlled release system for topical delivery of terbinafine hydrochloride. Eur J Pharm Sci. 2013;49(2):311\u201322. https:\/\/doi.org\/10.1016\/j.ejps.2013.03.013.","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"3561_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jddst.2023.104709","volume":"86","author":"M Akanda","year":"2023","unstructured":"Akanda M, Mithu MDSH, Douroumis D. Solid lipid nanoparticles: an effective lipid-based technology for cancer treatment. J Drug Deliv Sci Technol. 2023;86(1):1\u201314. https:\/\/doi.org\/10.1016\/j.jddst.2023.104709.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3561_CR9","doi-asserted-by":"publisher","unstructured":"Llaguno-Munive M, Vazquez-Lopez MI, Garcia-Lopez P. Solid Lipid Nanoparticles, an Alternative for the Treatment of Triple-Negative Breast Cancer Preprints 2024;25(19):1\u201320. https:\/\/doi.org\/10.20944\/preprints202407.1829.v1.","DOI":"10.20944\/preprints202407.1829.v1"},{"key":"3561_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4137\/BCBCR.S8205","volume":"6","author":"WJ Gradishar","year":"2012","unstructured":"Gradishar WJ. Taxanes for the treatment of metastatic breast cancer. Breast Cancer (Auckl). 2012;6:159\u201371. https:\/\/doi.org\/10.4137\/BCBCR.S8205.","journal-title":"Breast Cancer (Auckl)"},{"issue":"7","key":"3561_CR11","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1021\/acs.molpharmaceut.5b00081","volume":"12","author":"G Fang","year":"2015","unstructured":"Fang G, Tang B, Chao Y, Xu H, Gou J, Zhang Y, et al. Cysteine-Functionalized Nanostructured Lipid Carriers for Oral Delivery of Docetaxel: A Permeability and Pharmacokinetic Study. Mol Pharm. 2015;12(7):2384\u201395. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.5b00081.","journal-title":"Mol Pharm"},{"key":"3561_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.colsurfb.2018.09.047","volume":"173","author":"S Lakkadwala","year":"2019","unstructured":"Lakkadwala S, Singh J. Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model. Colloids Surf B Biointerfaces. 2019;173:27\u201335. https:\/\/doi.org\/10.1016\/j.colsurfb.2018.09.047.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"3561_CR13","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.carbpol.2015.10.080","volume":"137","author":"CP Dora","year":"2016","unstructured":"Dora CP, Trotta F, Kushwah V, Devasari N, Singh C, Suresh S, et al. Potential of erlotinib cyclodextrin nanosponge complex to enhance solubility, dissolution rate, in vitro cytotoxicity and oral bioavailability. Carbohydr Polym. 2016;137:339\u201349. https:\/\/doi.org\/10.1016\/j.carbpol.2015.10.080.","journal-title":"Carbohydr Polym"},{"issue":"10","key":"3561_CR14","doi-asserted-by":"publisher","first-page":"5512","DOI":"10.1039\/c9ra00276f","volume":"9","author":"M Lei","year":"2019","unstructured":"Lei M, Sha S, Wang X, Wang J, Du X, Miao H, et al. Co-delivery of paclitaxel and gemcitabine via a self-assembling nanoparticle for targeted treatment of breast cancer. RSC Adv. 2019;9(10):5512\u201320. https:\/\/doi.org\/10.1039\/c9ra00276f.","journal-title":"RSC Adv"},{"key":"3561_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2024.114386","volume":"201","author":"A Chaudhuri","year":"2024","unstructured":"Chaudhuri A, Naveen Kumar D, Kumar D, Kumar AA. Functionalized solid lipid nanoparticles combining docetaxel and erlotinib synergize the anticancer efficacy against triple-negative breast cancer. Eur J Pharm Biopharm. 2024;201:114386. https:\/\/doi.org\/10.1016\/j.ejpb.2024.114386.","journal-title":"Eur J Pharm Biopharm"},{"issue":"43","key":"3561_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-020-00604-7","volume":"18","author":"MCO da Rocha","year":"2020","unstructured":"da Rocha MCO, da Silva PB, Radicchi MA, Andrade BYG, de Oliveira JV, Venus T, et al. Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells. J Nanobiotechnology. 2020;18(43):1\u201320. https:\/\/doi.org\/10.1186\/s12951-020-00604-7.","journal-title":"J Nanobiotechnology"},{"key":"3561_CR17","doi-asserted-by":"publisher","first-page":"8059","DOI":"10.2147\/IJN.S269340","volume":"15","author":"WN Ibrahim","year":"2020","unstructured":"Ibrahim WN, Muizzuddin Bin Mohd Rosli L, Doolaanea AA. Formulation, cellular uptake and cytotoxicity of thymoquinone-loaded PLGA nanoparticles in malignant melanoma cancer cells. Int J Nanomedicine. 2020;15:8059\u201374. https:\/\/doi.org\/10.2147\/IJN.S269340.","journal-title":"Int J Nanomedicine"},{"issue":"11","key":"3561_CR18","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.1002\/cam4.881","volume":"5","author":"F Shan","year":"2016","unstructured":"Shan F, Shao Z, Jiang S, Cheng Z. Erlotinib induces the human non-small-cell lung cancer cells apoptosis via activating ROS-dependent JNK pathways. Cancer Med. 2016;5(11):3166\u201375. https:\/\/doi.org\/10.1002\/cam4.881.","journal-title":"Cancer Med"},{"issue":"1614","key":"3561_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-38214-x","volume":"9","author":"N Nordin","year":"2019","unstructured":"Nordin N, Yeap SK, Rahman HS, Zamberi NR, Abu N, Mohamad NE, et al. In vitro cytotoxicity and anticancer effects of citral nanostructured lipid carrier on MDA MBA-231 human breast cancer cells. Sci Rep. 2019;9(1614):1\u201319. https:\/\/doi.org\/10.1038\/s41598-018-38214-x.","journal-title":"Sci Rep"},{"issue":"8","key":"3561_CR20","first-page":"1","volume":"12","author":"DN Kumar","year":"2022","unstructured":"Kumar DN, Chaudhuri A, Dehari D, Shekher A, Gupta SC, Majumdar S, et al. Combination therapy comprising paclitaxel and 5-fluorouracil by using folic acid functionalized bovine milk exosomes improves the therapeutic efficacy against breast cancer. Life (Basel). 2022;12(8):1\u201320.","journal-title":"Life (Basel)"},{"issue":"1","key":"3561_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/10837450.2021.2022693","volume":"27","author":"M Dousti","year":"2022","unstructured":"Dousti M, Sari S, Saffari M, Kelidari H, Asare-Addo K, Nokhodchi A. Loading Pistacia atlantica essential oil in solid lipid nanoparticles and its effect on apoptosis of breast cancer cell line MDA-MB-231. Pharm Dev Technol. 2022;27(1):63\u201371. https:\/\/doi.org\/10.1080\/10837450.2021.2022693.","journal-title":"Pharm Dev Technol"},{"key":"3561_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23071578","author":"W Wang","year":"2018","unstructured":"Wang W, Chen T, Xu H, Ren B, Cheng X, Qi R, et al. Curcumin-loaded solid lipid nanoparticles enhanced anticancer efficiency in breast cancer. Molecules. 2018. https:\/\/doi.org\/10.3390\/molecules23071578.","journal-title":"Molecules"},{"issue":"4","key":"3561_CR23","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.3892\/or.2018.6599","volume":"40","author":"J Zhu","year":"2018","unstructured":"Zhu J, Cai Y, Xu K, Ren X, Sun J, Lu S, et al. Beclin1 overexpression suppresses tumor cell proliferation and survival via an autophagy\u2011dependent pathway in human synovial sarcoma cells. Oncol Rep. 2018;40(4):1927\u201336. https:\/\/doi.org\/10.3892\/or.2018.6599.","journal-title":"Oncol Rep"},{"issue":"3","key":"3561_CR24","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00432-017-2557-5","volume":"144","author":"Z Hamurcu","year":"2018","unstructured":"Hamurcu Z, Delibasi N, Gecene S, Sener EF, Donmez-Altuntas H, Ozkul Y, et al. Targeting LC3 and Beclin-1 autophagy genes suppresses proliferation, survival, migration and invasion by inhibition of Cyclin-D1 and uPAR\/Integrin beta1\/ Src signaling in triple negative breast cancer cells. J Cancer Res Clin Oncol. 2018;144(3):415\u201330. https:\/\/doi.org\/10.1007\/s00432-017-2557-5.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"3561_CR25","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1038\/nprot.2006.339","volume":"1","author":"NA Franken","year":"2006","unstructured":"Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C. Clonogenic assay of cells in vitro. Nat Protoc. 2006;1(5):2315\u20139. https:\/\/doi.org\/10.1038\/nprot.2006.339.","journal-title":"Nat Protoc"},{"issue":"114","key":"3561_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/medicina55040114","volume":"55","author":"F Niazvand","year":"2019","unstructured":"Niazvand F, Orazizadeh M, Khorsandi L, Abbaspour M, Mansouri E, Khodadadi A. Effects of Quercetin-Loaded nanoparticles on MCF-7 human breast cancer cells. Medicina (Kaunas). 2019;55(114):1\u201315. https:\/\/doi.org\/10.3390\/medicina55040114.","journal-title":"Medicina (Kaunas)"},{"issue":"23","key":"3561_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers13236114","volume":"13","author":"S Haque","year":"2021","unstructured":"Haque S, Norbert CC, Acharyya R, Mukherjee S, Kathirvel M, Patra CR. Biosynthesized silver nanoparticles for cancer therapy and in vivo bioimaging. Cancers (Basel). 2021;13(23):1\u201326. https:\/\/doi.org\/10.3390\/cancers13236114.","journal-title":"Cancers (Basel)"},{"key":"3561_CR28","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2147\/IJN.S148487","volume":"13","author":"G Deng","year":"2018","unstructured":"Deng G, Zhou F, Wu Z, Zhang F, Niu K, Kang Y, et al. Inhibition of cancer cell migration with CuS@ mSiO(2)-PEG nanoparticles by repressing MMP-2\/MMP-9 expression. Int J Nanomedicine. 2018;13:103\u201316. https:\/\/doi.org\/10.2147\/IJN.S148487.","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"3561_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-17333-6","volume":"12","author":"N Chaurawal","year":"2022","unstructured":"Chaurawal N, Misra C, Abul Barkat H, Jatyan R, Chitkara D, Barkat MA, et al. Oral sorafenib-loaded microemulsion for breast cancer: evidences from the in-vitro evaluations and pharmacokinetic studies. Sci Rep. 2022;12(1):1\u201315. https:\/\/doi.org\/10.1038\/s41598-022-17333-6.","journal-title":"Sci Rep"},{"issue":"11","key":"3561_CR30","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.1021\/acs.molpharmaceut.6b00691","volume":"13","author":"D Pooja","year":"2016","unstructured":"Pooja D, Kulhari H, Kuncha M, Rachamalla SS, Adams DJ, Bansal V, et al. Improving efficacy, oral bioavailability, and delivery of paclitaxel using protein-grafted solid lipid nanoparticles. Mol Pharm. 2016;13(11):3903\u201312. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.6b00691.","journal-title":"Mol Pharm"},{"key":"3561_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12645-022-00120-3","author":"PS Mirzaghavami","year":"2022","unstructured":"Mirzaghavami PS, Khoei S, Khoee S, Shirvalilou S. Folic acid-conjugated magnetic triblock copolymer nanoparticles for dual targeted delivery of 5-fluorouracil to colon cancer cells. Cancer Nanotechnol. 2022. https:\/\/doi.org\/10.1186\/s12645-022-00120-3.","journal-title":"Cancer Nanotechnol"},{"key":"3561_CR32","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.2147\/IJN.S400329","volume":"18","author":"QT Fu","year":"2023","unstructured":"Fu QT, Zhong XQ, Chen MY, Gu JY, Zhao J, Yu DH, et al. Luteolin-Loaded Nanoparticles for the Treatment of Melanoma. Int J Nanomedicine. 2023;18:2053\u201368. https:\/\/doi.org\/10.2147\/IJN.S400329.","journal-title":"Int J Nanomedicine"},{"issue":"105657","key":"3561_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejps.2020.105657","volume":"158","author":"V Sethuraman","year":"2021","unstructured":"Sethuraman V, Janakiraman K, Krishnaswami V, Natesan S, Kandasamy R. In vivo synergistic anti-tumor effect of lumefantrine combined with pH responsive behavior of nano calcium phosphate based lipid nanoparticles on lung cancer. Eur J Pharm Sci. 2021;158(105657):1\u201310. https:\/\/doi.org\/10.1016\/j.ejps.2020.105657.","journal-title":"Eur J Pharm Sci"},{"issue":"7","key":"3561_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics15071796","volume":"15","author":"O Obidiro","year":"2023","unstructured":"Obidiro O, Battogtokh G, Akala EO. Triple negative breast cancer treatment options and limitations: future outlook. Pharmaceutics. 2023;15(7):1\u201326. https:\/\/doi.org\/10.3390\/pharmaceutics15071796.","journal-title":"Pharmaceutics"},{"issue":"5","key":"3561_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ph15050542","volume":"15","author":"A Chaudhuri","year":"2022","unstructured":"Chaudhuri A, Kumar DN, Dehari D, Singh S, Kumar P, Bolla PK, et al. Emergence of nanotechnology as a powerful cavalry against triple-negative breast cancer (TNBC). Pharmaceuticals (Basel). 2022;15(5):1\u201363. https:\/\/doi.org\/10.3390\/ph15050542.","journal-title":"Pharmaceuticals (Basel)"},{"key":"3561_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biopha.2023.116084","volume":"170","author":"Y Wang","year":"2024","unstructured":"Wang Y, Cheng W, Zhu J, He L, Ren W, Bao D, et al. Programmed co-delivery of tamoxifen and docetaxel using lipid-coated mesoporous silica nanoparticles for overcoming CYP3A4-mediated resistance in triple-negative breast cancer treatment. Biomed Pharmacother. 2024;170:1\u201327. https:\/\/doi.org\/10.1016\/j.biopha.2023.116084.","journal-title":"Biomed Pharmacother"},{"key":"3561_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cej.2022.135305","volume":"437","author":"Y Liu","year":"2022","unstructured":"Liu Y, Ma X, Zhu Y, Lv X, Wang P, Feng L. pH-responsive nanomedicine co-encapsulated with Erlotinib and chlorin e6 can enable effective treatment of triple negative breast cancer via reprogramming tumor vasculature. Chem Eng J. 2022;437:1\u201317. https:\/\/doi.org\/10.1016\/j.cej.2022.135305.","journal-title":"Chem Eng J"},{"key":"3561_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.matdes.2020.109230","author":"C-C Weng","year":"2021","unstructured":"Weng C-C, Yang T-A, Li Y-K. Design and fabrication of cell-targeted, dual drug-loaded nanoparticles with pH-controlled drug release and near-infrared light-induced photothermal effects. Mater Des. 2021. https:\/\/doi.org\/10.1016\/j.matdes.2020.109230.","journal-title":"Mater Des"},{"issue":"5","key":"3561_CR39","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/j.nano.2018.04.009","volume":"14","author":"V Kushwah","year":"2018","unstructured":"Kushwah V, Katiyar SS, Agrawal AK, Gupta RC, Jain S. Co-delivery of docetaxel and gemcitabine using PEGylated self-assembled stealth nanoparticles for improved breast cancer therapy. Nanomedicine. 2018;14(5):1629\u201341. https:\/\/doi.org\/10.1016\/j.nano.2018.04.009.","journal-title":"Nanomedicine"},{"key":"3561_CR40","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.colsurfb.2016.05.051","volume":"146","author":"NK Garg","year":"2016","unstructured":"Garg NK, Singh B, Jain A, Nirbhavane P, Sharma R, Tyagi RK, et al. Fucose decorated solid-lipid nanocarriers mediate efficient delivery of methotrexate in breast cancer therapeutics. Colloids Surf B Biointerfaces. 2016;146:114\u201326. https:\/\/doi.org\/10.1016\/j.colsurfb.2016.05.051.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"7","key":"3561_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-016-0245-2","volume":"15","author":"T Wang","year":"2017","unstructured":"Wang T, Hou J, Su C, Zhao L, Shi Y. Hyaluronic acid-coated chitosan nanoparticles induce ROS-mediated tumor cell apoptosis and enhance antitumor efficiency by targeted drug delivery via CD44. J Nanobiotechnology. 2017;15(7):1\u201312. https:\/\/doi.org\/10.1186\/s12951-016-0245-2.","journal-title":"J Nanobiotechnology"},{"issue":"11","key":"3561_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nano11113154","volume":"11","author":"R Mohammed Asik","year":"2021","unstructured":"Mohammed Asik R, Manikkaraja C, Tamil Surya K, Suganthy N, Priya Aarthy A, Mathe D, et al. Anticancer Potential of L-Histidine-Capped Silver Nanoparticles against Human Cervical Cancer Cells (SiHA). Nanomaterials (Basel). 2021;11(11):1\u201317. https:\/\/doi.org\/10.3390\/nano11113154.","journal-title":"Nanomaterials (Basel)"},{"issue":"6","key":"3561_CR43","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1021\/acs.molpharmaceut.3c01186","volume":"21","author":"MG Fuster","year":"2024","unstructured":"Fuster MG, Wang J, Fandino O, Villora G, Paredes AJ. Folic acid-decorated nanocrystals as highly loaded trojan horses to target cancer cells. Mol Pharm. 2024;21(6):2781\u201394. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.3c01186.","journal-title":"Mol Pharm"},{"key":"3561_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/cells11121863","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Grunberger JW, Khurana N, Zhou X, Xu X, Ghandehari H, et al. BECLIN-1-mediated autophagy suppresses silica nanoparticle-induced testicular toxicity via the inhibition of caspase 8-mediated cell apoptosis in Leydig cells. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11121863.","journal-title":"Cells"},{"key":"3561_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28031393","author":"A De","year":"2023","unstructured":"De A, Roychowdhury P, Bhuyan NR, Ko YT, Singh SK, Dua K, et al. Folic acid functionalized diallyl trisulfide-solid lipid nanoparticles for targeting triple negative breast cancer. Molecules. 2023. https:\/\/doi.org\/10.3390\/molecules28031393.","journal-title":"Molecules"},{"key":"3561_CR46","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.2147\/IJN.S249240","volume":"15","author":"S Ayyanaar","year":"2020","unstructured":"Ayyanaar S, Balachandran C, Bhaskar RC, Kesavan MP, Aoki S, Raja RP, et al. ROS-Responsive Chitosan Coated Magnetic Iron Oxide Nanoparticles as Potential Vehicles for Targeted Drug Delivery in Cancer Therapy. Int J Nanomedicine. 2020;15:3333\u201346. https:\/\/doi.org\/10.2147\/IJN.S249240.","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"3561_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-81701-x","volume":"11","author":"M Kumari","year":"2021","unstructured":"Kumari M, Sharma N, Manchanda R, Gupta N, Syed A, Bahkali AH, et al. PGMD\/curcumin nanoparticles for the treatment of breast cancer. Sci Rep. 2021;11(1):1\u201317. https:\/\/doi.org\/10.1038\/s41598-021-81701-x.","journal-title":"Sci Rep"},{"key":"3561_CR48","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.bcp.2017.07.013","volume":"143","author":"X Qin","year":"2017","unstructured":"Qin X, Lu J, Wang P, Xu P, Liu M, Wang X. Cytochrome P450 3A selectively affects the pharmacokinetic interaction between erlotinib and docetaxel in rats. Biochem Pharmacol. 2017;143:129\u201339. https:\/\/doi.org\/10.1016\/j.bcp.2017.07.013.","journal-title":"Biochem Pharmacol"},{"issue":"127","key":"3561_CR49","doi-asserted-by":"publisher","first-page":"105179","DOI":"10.1039\/c5ra19115g","volume":"5","author":"AK Agrawal","year":"2015","unstructured":"Agrawal AK, Urimi D, Harde H, Kushwah V, Jain S. Folate appended chitosan nanoparticles augment the stability, bioavailability and efficacy of insulin in diabetic rats following oral administration. RSC Adv. 2015;5(127):105179\u201393. https:\/\/doi.org\/10.1039\/c5ra19115g.","journal-title":"RSC Adv"},{"issue":"43","key":"3561_CR50","doi-asserted-by":"publisher","first-page":"17498","DOI":"10.1073\/pnas.1313839110","volume":"110","author":"S Attili-Qadri","year":"2013","unstructured":"Attili-Qadri S, Karra N, Nemirovski A, Schwob O, Talmon Y, Nassar T, et al. Oral delivery system prolongs blood circulation of docetaxel nanocapsules via lymphatic absorption. Proc Natl Acad Sci U S A. 2013;110(43):17498\u2013503. https:\/\/doi.org\/10.1073\/pnas.1313839110.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3561_CR51","doi-asserted-by":"publisher","first-page":"8055","DOI":"10.2147\/OTT.S259428","volume":"13","author":"P Yang","year":"2020","unstructured":"Yang P, Zhang L, Wang T, Liu Q, Wang J, Wang Y, et al. Doxorubicin and Edelfosine Combo-Loaded Lipid-Polymer Hybrid Nanoparticles for Synergistic Anticancer Effect Against Drug-Resistant Osteosarcoma. Onco Targets Ther. 2020;13:8055\u201367. https:\/\/doi.org\/10.2147\/OTT.S259428.","journal-title":"Onco Targets Ther"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03561-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03561-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03561-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:37:21Z","timestamp":1790793441000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03561-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":51,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["3561"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03561-w","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"assertion":[{"value":"1 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"320"}}